Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rarg
|
ENSMUSG00000001288.8 | retinoic acid receptor, gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102250326_102250587 | Rarg | 110 | 0.925451 | 0.31 | 1.4e-02 | Click! |
chr15_102249163_102250297 | Rarg | 616 | 0.536670 | 0.27 | 3.7e-02 | Click! |
chr15_102251977_102252209 | Rarg | 547 | 0.585379 | 0.27 | 4.0e-02 | Click! |
chr15_102254048_102254447 | Rarg | 1607 | 0.203307 | 0.26 | 4.4e-02 | Click! |
chr15_102258345_102258496 | Rarg | 903 | 0.369229 | 0.25 | 5.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_7966827_7967869 | 5.70 |
Gata1 |
GATA binding protein 1 |
562 |
0.55 |
chr11_102360845_102363484 | 5.51 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr19_10015065_10016667 | 5.43 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr7_16784339_16784989 | 5.11 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
74 |
0.95 |
chr6_5255342_5256653 | 4.93 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr15_103250315_103251530 | 4.85 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr2_32078207_32079756 | 4.61 |
Fam78a |
family with sequence similarity 78, member A |
371 |
0.77 |
chr13_58522751_58523890 | 3.97 |
Gm3131 |
predicted gene 3131 |
22708 |
0.16 |
chr8_23038726_23039184 | 3.89 |
Ank1 |
ankyrin 1, erythroid |
3724 |
0.22 |
chr11_102895188_102895912 | 3.70 |
Gfap |
glial fibrillary acidic protein |
1581 |
0.23 |
chr12_32104342_32104636 | 3.57 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19213 |
0.16 |
chr11_96942711_96943051 | 3.55 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
898 |
0.32 |
chr17_48300015_48301474 | 3.55 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr6_122393147_122393385 | 3.54 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
1887 |
0.24 |
chr10_75937829_75938478 | 3.45 |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
933 |
0.28 |
chr16_32509209_32509642 | 3.45 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9814 |
0.13 |
chr13_23753509_23754202 | 3.43 |
H3c2 |
H3 clustered histone 2 |
1588 |
0.1 |
chr9_89879614_89881129 | 3.43 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
29537 |
0.16 |
chr9_22134719_22135019 | 3.34 |
Acp5 |
acid phosphatase 5, tartrate resistant |
822 |
0.35 |
chr12_84150828_84152588 | 3.27 |
Pnma1 |
paraneoplastic antigen MA1 |
3219 |
0.13 |
chr11_119392018_119392570 | 3.23 |
Rnf213 |
ring finger protein 213 |
806 |
0.49 |
chr12_86891509_86893562 | 3.17 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
7737 |
0.19 |
chr2_158145151_158146425 | 2.98 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr3_101551232_101552184 | 2.97 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
25852 |
0.16 |
chr10_111594457_111595800 | 2.95 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
855 |
0.55 |
chr7_142576289_142578620 | 2.95 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr8_122697547_122698708 | 2.94 |
Gm10612 |
predicted gene 10612 |
267 |
0.75 |
chr6_136855492_136855648 | 2.93 |
Art4 |
ADP-ribosyltransferase 4 |
2163 |
0.16 |
chr2_103958009_103958847 | 2.89 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr17_25944012_25944589 | 2.83 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
210 |
0.7 |
chr4_140683708_140683975 | 2.80 |
Gm13025 |
predicted gene 13025 |
4088 |
0.14 |
chr19_29068022_29068464 | 2.80 |
Gm9895 |
predicted gene 9895 |
896 |
0.45 |
chr1_133245733_133247220 | 2.74 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
370 |
0.84 |
chr7_80296014_80296242 | 2.72 |
Prc1 |
protein regulator of cytokinesis 1 |
1615 |
0.21 |
chr5_143625482_143626083 | 2.72 |
Cyth3 |
cytohesin 3 |
3248 |
0.24 |
chr8_13202008_13202379 | 2.72 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
1373 |
0.23 |
chr4_123563785_123564109 | 2.72 |
Macf1 |
microtubule-actin crosslinking factor 1 |
747 |
0.67 |
chr12_32111429_32112319 | 2.70 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
11828 |
0.18 |
chr15_103253562_103255772 | 2.68 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr3_30010716_30011762 | 2.65 |
Mecom |
MDS1 and EVI1 complex locus |
200 |
0.91 |
chr14_76532606_76533942 | 2.64 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr12_103630582_103631271 | 2.63 |
Serpina10 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
495 |
0.69 |
chr3_84189998_84191469 | 2.63 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr7_142654280_142656231 | 2.62 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr17_85686512_85689764 | 2.62 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr17_29841641_29842774 | 2.61 |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
214 |
0.93 |
chr2_170153321_170154276 | 2.60 |
Zfp217 |
zinc finger protein 217 |
5695 |
0.31 |
chr18_61651079_61652393 | 2.59 |
Mir143 |
microRNA 143 |
2478 |
0.16 |
chr5_139390751_139391547 | 2.59 |
Gpr146 |
G protein-coupled receptor 146 |
1364 |
0.29 |
chr9_65128098_65129057 | 2.57 |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
12612 |
0.13 |
chr11_97434598_97436859 | 2.56 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr14_66279066_66281333 | 2.55 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr3_14889110_14890285 | 2.55 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr5_73189782_73190392 | 2.55 |
Gm42571 |
predicted gene 42571 |
330 |
0.81 |
chr19_29126810_29127736 | 2.55 |
Mir101b |
microRNA 101b |
8006 |
0.14 |
chr9_21029266_21030734 | 2.53 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr18_60500309_60500522 | 2.53 |
Smim3 |
small integral membrane protein 3 |
1161 |
0.44 |
chr2_74678970_74680401 | 2.49 |
Hoxd11 |
homeobox D11 |
128 |
0.86 |
chr3_153908033_153909893 | 2.47 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr5_113973724_113975031 | 2.47 |
Ssh1 |
slingshot protein phosphatase 1 |
7621 |
0.13 |
chr5_44224329_44225221 | 2.46 |
Gm42983 |
predicted gene 42983 |
265 |
0.82 |
chr1_55085586_55086072 | 2.45 |
Hspd1 |
heat shock protein 1 (chaperonin) |
2195 |
0.17 |
chr18_84858127_84859558 | 2.45 |
Gm16146 |
predicted gene 16146 |
705 |
0.62 |
chr6_41703661_41704308 | 2.44 |
Kel |
Kell blood group |
355 |
0.81 |
chr15_99032182_99033105 | 2.43 |
Tuba1c |
tubulin, alpha 1C |
2322 |
0.15 |
chr4_46403560_46404035 | 2.43 |
Hemgn |
hemogen |
439 |
0.76 |
chr8_57326741_57329467 | 2.43 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr1_64732784_64733795 | 2.42 |
Gm38058 |
predicted gene, 38058 |
2951 |
0.21 |
chr2_154632073_154632660 | 2.42 |
Gm14198 |
predicted gene 14198 |
270 |
0.85 |
chr10_69925300_69927130 | 2.40 |
Ank3 |
ankyrin 3, epithelial |
82 |
0.99 |
chr4_140813807_140815024 | 2.40 |
Gm13032 |
predicted gene 13032 |
3422 |
0.16 |
chr17_29493756_29495031 | 2.40 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr5_114969022_114970855 | 2.38 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr4_130173825_130175545 | 2.37 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr10_93890810_93891154 | 2.36 |
Metap2 |
methionine aminopeptidase 2 |
147 |
0.93 |
chr11_106674489_106675245 | 2.35 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
11541 |
0.17 |
chr19_6968781_6970375 | 2.33 |
Plcb3 |
phospholipase C, beta 3 |
130 |
0.89 |
chr11_70614847_70615992 | 2.32 |
Chrne |
cholinergic receptor, nicotinic, epsilon polypeptide |
254 |
0.58 |
chr11_95338701_95339435 | 2.30 |
Fam117a |
family with sequence similarity 117, member A |
863 |
0.43 |
chr2_165884922_165885215 | 2.29 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
194 |
0.92 |
chr7_99594627_99596228 | 2.29 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr11_102145120_102148094 | 2.28 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr2_167588684_167589456 | 2.28 |
Gm11475 |
predicted gene 11475 |
2325 |
0.19 |
chr5_137115306_137115463 | 2.27 |
Trim56 |
tripartite motif-containing 56 |
823 |
0.47 |
chr9_40323395_40324376 | 2.27 |
1700110K17Rik |
RIKEN cDNA 1700110K17 gene |
459 |
0.71 |
chr5_96951041_96951747 | 2.24 |
Gm43144 |
predicted gene 43144 |
11097 |
0.1 |
chr7_19691393_19692666 | 2.24 |
Apoc1 |
apolipoprotein C-I |
462 |
0.59 |
chr10_80570596_80572042 | 2.24 |
Klf16 |
Kruppel-like factor 16 |
6002 |
0.08 |
chr11_115899671_115901427 | 2.23 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr1_120269879_120270612 | 2.22 |
Steap3 |
STEAP family member 3 |
178 |
0.96 |
chr7_79841260_79842229 | 2.21 |
Anpep |
alanyl (membrane) aminopeptidase |
608 |
0.6 |
chr2_30716357_30717429 | 2.21 |
Gm14488 |
predicted gene 14488 |
150 |
0.94 |
chr11_44528978_44529659 | 2.21 |
Rnf145 |
ring finger protein 145 |
9013 |
0.18 |
chr2_163643547_163643698 | 2.21 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
1228 |
0.31 |
chr5_134912761_134912970 | 2.19 |
Cldn13 |
claudin 13 |
2661 |
0.12 |
chr4_46042257_46042918 | 2.19 |
Tmod1 |
tropomodulin 1 |
3378 |
0.24 |
chr4_136175795_136176646 | 2.19 |
E2f2 |
E2F transcription factor 2 |
3826 |
0.17 |
chr12_7978894_7979569 | 2.18 |
Apob |
apolipoprotein B |
1452 |
0.45 |
chr7_127767459_127768302 | 2.18 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chr11_84824089_84824339 | 2.16 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
4699 |
0.13 |
chr8_57320946_57324000 | 2.16 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr11_109587022_109588156 | 2.16 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr11_99043636_99045890 | 2.16 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr11_58920267_58920694 | 2.15 |
Btnl10 |
butyrophilin-like 10 |
2423 |
0.11 |
chr3_96401612_96402551 | 2.15 |
4930477E14Rik |
RIKEN cDNA 4930477E14 gene |
67 |
0.75 |
chr8_70765697_70766944 | 2.13 |
6330537M06Rik |
RIKEN cDNA 6330537M06 gene |
259 |
0.52 |
chr11_84821499_84821722 | 2.13 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
2095 |
0.21 |
chr8_122546551_122549259 | 2.13 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr1_58969882_58970334 | 2.12 |
Trak2 |
trafficking protein, kinesin binding 2 |
3321 |
0.18 |
chr5_74064229_74066220 | 2.11 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr11_104309715_104311017 | 2.10 |
Mapt |
microtubule-associated protein tau |
7667 |
0.17 |
chr11_87756102_87757558 | 2.10 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr11_117781898_117782456 | 2.10 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr4_46040988_46042013 | 2.09 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr11_72999160_73000159 | 2.09 |
P2rx1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
344 |
0.81 |
chr3_115758693_115759280 | 2.08 |
Gm9889 |
predicted gene 9889 |
43836 |
0.13 |
chr14_70704541_70705363 | 2.08 |
Xpo7 |
exportin 7 |
3083 |
0.2 |
chr16_4552537_4553851 | 2.08 |
Tfap4 |
transcription factor AP4 |
232 |
0.9 |
chr3_127123282_127124895 | 2.07 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr3_116860395_116860804 | 2.07 |
Frrs1 |
ferric-chelate reductase 1 |
1032 |
0.41 |
chr7_29124042_29125535 | 2.06 |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
227 |
0.84 |
chr9_46228849_46229438 | 2.06 |
Apoa1 |
apolipoprotein A-I |
422 |
0.68 |
chr1_184729496_184731200 | 2.05 |
Hlx |
H2.0-like homeobox |
1250 |
0.37 |
chr15_75893368_75894708 | 2.04 |
Naprt |
nicotinate phosphoribosyltransferase |
252 |
0.8 |
chr18_38247513_38247944 | 2.02 |
1700086O06Rik |
RIKEN cDNA 1700086O06 gene |
2150 |
0.16 |
chr19_40812757_40814183 | 2.02 |
Ccnj |
cyclin J |
17809 |
0.16 |
chr2_173024069_173026002 | 2.02 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr15_76228803_76230238 | 2.00 |
Plec |
plectin |
23 |
0.94 |
chr9_64017614_64019400 | 2.00 |
Smad6 |
SMAD family member 6 |
1520 |
0.33 |
chr3_14888603_14889051 | 2.00 |
Car2 |
carbonic anhydrase 2 |
2188 |
0.31 |
chr5_139732367_139733376 | 2.00 |
Micall2 |
MICAL-like 2 |
37 |
0.97 |
chr14_63244119_63245953 | 1.99 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr8_23042156_23042447 | 1.99 |
Ank1 |
ankyrin 1, erythroid |
7070 |
0.19 |
chr13_21914897_21915219 | 1.98 |
Gm44456 |
predicted gene, 44456 |
9958 |
0.06 |
chr2_121034400_121034686 | 1.98 |
Epb42 |
erythrocyte membrane protein band 4.2 |
2138 |
0.19 |
chr5_137610176_137611504 | 1.96 |
Pcolce |
procollagen C-endopeptidase enhancer protein |
138 |
0.86 |
chr8_70511356_70511507 | 1.96 |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
630 |
0.48 |
chr10_44380217_44380973 | 1.96 |
Mir1929 |
microRNA 1929 |
20919 |
0.18 |
chr12_33315477_33315814 | 1.95 |
Atxn7l1 |
ataxin 7-like 1 |
240 |
0.94 |
chr13_98810152_98810868 | 1.94 |
Fcho2 |
FCH domain only 2 |
4643 |
0.14 |
chr14_70622968_70623362 | 1.94 |
Dmtn |
dematin actin binding protein |
2990 |
0.16 |
chr2_135536052_135537171 | 1.93 |
9630028H03Rik |
RIKEN cDNA 9630028H03 gene |
46685 |
0.17 |
chr4_124701261_124701890 | 1.93 |
Fhl3 |
four and a half LIM domains 3 |
855 |
0.37 |
chr6_38342777_38343261 | 1.93 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
11254 |
0.13 |
chr11_97442581_97443059 | 1.92 |
Arhgap23 |
Rho GTPase activating protein 23 |
6535 |
0.17 |
chr11_103102696_103105788 | 1.92 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr2_45115821_45117555 | 1.91 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
707 |
0.69 |
chr9_108080430_108080966 | 1.91 |
Mst1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
215 |
0.71 |
chr6_127581934_127583022 | 1.91 |
Cracr2a |
calcium release activated channel regulator 2A |
4503 |
0.24 |
chr2_26576901_26577217 | 1.91 |
Egfl7 |
EGF-like domain 7 |
2955 |
0.12 |
chr4_132397551_132398511 | 1.91 |
Phactr4 |
phosphatase and actin regulator 4 |
168 |
0.89 |
chr11_102308792_102311562 | 1.90 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
269 |
0.84 |
chr4_123286782_123287699 | 1.90 |
Gm25788 |
predicted gene, 25788 |
4104 |
0.11 |
chr14_69269425_69270999 | 1.89 |
Gm27222 |
predicted gene 27222 |
11066 |
0.09 |
chr4_41096220_41096829 | 1.89 |
Aqp3 |
aquaporin 3 |
1659 |
0.24 |
chr2_113847625_113848666 | 1.88 |
Arhgap11a |
Rho GTPase activating protein 11A |
152 |
0.96 |
chr8_94985013_94985221 | 1.88 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
451 |
0.73 |
chr5_109557571_109558777 | 1.87 |
Crlf2 |
cytokine receptor-like factor 2 |
762 |
0.58 |
chr1_149960555_149961570 | 1.87 |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
193 |
0.96 |
chr4_43038101_43038323 | 1.86 |
Fam214b |
family with sequence similarity 214, member B |
911 |
0.4 |
chr15_79693581_79694713 | 1.86 |
Gtpbp1 |
GTP binding protein 1 |
33 |
0.94 |
chr4_154881074_154881465 | 1.86 |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
940 |
0.45 |
chr6_125190084_125190312 | 1.85 |
Ncapd2 |
non-SMC condensin I complex, subunit D2 |
1292 |
0.17 |
chr5_31251110_31252754 | 1.85 |
Krtcap3 |
keratinocyte associated protein 3 |
5 |
0.93 |
chr12_95693703_95697493 | 1.84 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
241 |
0.92 |
chr7_3704997_3705700 | 1.82 |
Rps9 |
ribosomal protein S9 |
268 |
0.79 |
chr2_180332745_180333375 | 1.82 |
Gata5os |
GATA binding protein 5, opposite strand |
203 |
0.89 |
chr4_154635108_154637998 | 1.82 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr7_127137113_127137433 | 1.82 |
Spn |
sialophorin |
541 |
0.55 |
chr13_102694089_102694588 | 1.81 |
Cd180 |
CD180 antigen |
727 |
0.72 |
chr6_124731783_124733196 | 1.81 |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
282 |
0.45 |
chr7_135722534_135722725 | 1.81 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
6268 |
0.17 |
chr2_163355804_163356111 | 1.80 |
Tox2 |
TOX high mobility group box family member 2 |
35579 |
0.12 |
chr6_86078066_86079298 | 1.80 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr13_21907152_21907974 | 1.80 |
Gm11279 |
predicted gene 11279 |
4407 |
0.08 |
chr4_134869303_134870057 | 1.79 |
Rhd |
Rh blood group, D antigen |
5144 |
0.18 |
chr11_79071961_79072528 | 1.79 |
Ksr1 |
kinase suppressor of ras 1 |
2242 |
0.33 |
chr18_38248552_38248782 | 1.79 |
1700086O06Rik |
RIKEN cDNA 1700086O06 gene |
1211 |
0.27 |
chr4_154023853_154024071 | 1.79 |
Smim1 |
small integral membrane protein 1 |
361 |
0.76 |
chr19_37436071_37437605 | 1.78 |
Hhex |
hematopoietically expressed homeobox |
99 |
0.94 |
chr17_71267313_71267689 | 1.78 |
Emilin2 |
elastin microfibril interfacer 2 |
1096 |
0.45 |
chr8_84722866_84724458 | 1.77 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr11_83285353_83286025 | 1.77 |
Slfn14 |
schlafen 14 |
1037 |
0.31 |
chr19_5724785_5726881 | 1.76 |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
437 |
0.54 |
chr12_110977793_110978288 | 1.76 |
Ankrd9 |
ankyrin repeat domain 9 |
215 |
0.89 |
chr11_78066635_78066850 | 1.76 |
Mir144 |
microRNA 144 |
6263 |
0.08 |
chr8_70630745_70631808 | 1.76 |
Gdf15 |
growth differentiation factor 15 |
819 |
0.39 |
chr14_69487673_69488235 | 1.76 |
Gm37094 |
predicted gene, 37094 |
12436 |
0.1 |
chr4_13784757_13786275 | 1.76 |
Runx1t1 |
RUNX1 translocation partner 1 |
734 |
0.79 |
chr17_27554827_27554978 | 1.75 |
Hmga1 |
high mobility group AT-hook 1 |
1595 |
0.15 |
chr2_84939414_84939569 | 1.75 |
Slc43a3 |
solute carrier family 43, member 3 |
2601 |
0.19 |
chr9_42460457_42460722 | 1.75 |
Tbcel |
tubulin folding cofactor E-like |
872 |
0.57 |
chr11_60810014_60810742 | 1.75 |
Shmt1 |
serine hydroxymethyltransferase 1 (soluble) |
713 |
0.45 |
chr8_25542987_25545804 | 1.74 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr8_84703616_84705950 | 1.74 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr19_47239858_47241187 | 1.74 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
11611 |
0.11 |
chr17_48302788_48303170 | 1.74 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
2593 |
0.18 |
chr3_101367155_101367578 | 1.74 |
Igsf3 |
immunoglobulin superfamily, member 3 |
9717 |
0.15 |
chr18_60646910_60648302 | 1.73 |
Synpo |
synaptopodin |
666 |
0.69 |
chr3_100485235_100486511 | 1.72 |
Tent5c |
terminal nucleotidyltransferase 5C |
3321 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.7 | 6.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.4 | 4.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.2 | 3.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 1.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.1 | 3.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.0 | 3.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.0 | 3.9 | GO:0003166 | bundle of His development(GO:0003166) |
1.0 | 5.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 0.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 3.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.8 | 5.9 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 2.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 3.3 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.8 | 2.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 2.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.8 | 2.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 3.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.7 | 2.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 2.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 2.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.7 | 2.8 | GO:0046618 | drug export(GO:0046618) |
0.7 | 1.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 2.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 2.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 2.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 2.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.9 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.6 | 3.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.6 | 3.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.6 | 3.1 | GO:0070627 | ferrous iron import(GO:0070627) |
0.6 | 1.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 3.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.6 | 2.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.6 | 2.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.6 | 1.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.6 | 1.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.6 | 1.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.6 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 2.2 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.6 | 1.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 2.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 1.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 2.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 2.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.5 | 3.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 1.6 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.5 | 2.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 1.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 10.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 1.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.5 | 0.5 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 1.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 3.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 1.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 1.0 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.5 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 1.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 1.4 | GO:0045472 | response to ether(GO:0045472) |
0.5 | 1.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.5 | 0.5 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.5 | 0.9 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.5 | 0.9 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 3.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 3.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 0.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.4 | 1.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 2.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.4 | 1.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 2.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 0.4 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.4 | 0.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.4 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 3.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 1.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 0.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.4 | 1.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 2.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 2.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.8 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.4 | 1.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 1.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 1.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.4 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 0.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.4 | 1.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.4 | 1.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 1.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.4 | 1.1 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 1.9 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 1.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 1.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 1.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.4 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 1.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 0.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.4 | 1.4 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.8 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 5.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 1.7 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 3.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 2.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.7 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 2.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 1.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.3 | 1.6 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 1.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 1.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 1.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 1.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 1.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.3 | 0.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 0.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 1.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 0.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 2.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.9 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 4.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 1.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 1.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 2.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.6 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 0.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 0.3 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 3.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 2.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 0.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 2.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.9 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.3 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 1.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 1.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.3 | 0.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 0.5 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 4.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 1.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.3 | 0.8 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 1.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.6 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 1.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 2.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 1.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 1.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.8 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 2.0 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 1.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 1.0 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 1.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 1.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.2 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 2.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 5.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 1.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.2 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 2.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 2.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.7 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.7 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.7 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 2.3 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 1.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 1.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 2.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 1.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 0.6 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 3.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.2 | 1.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 3.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 2.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 1.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.2 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 0.2 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 1.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.2 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.0 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 3.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.2 | 0.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 3.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 1.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.8 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.2 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 2.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.4 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 0.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.6 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 1.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 1.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 1.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.7 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.8 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 2.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 1.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 0.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 2.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 1.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.6 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.2 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.6 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.2 | 0.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.5 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 1.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 1.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.9 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 1.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 2.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.8 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 0.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.2 | 2.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.2 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.2 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 1.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 3.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.3 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.2 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 2.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.9 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 1.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 4.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.2 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.2 | 1.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.8 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 1.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 1.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.1 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 4.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 1.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 1.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 2.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 4.7 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.4 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.8 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 1.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 3.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 1.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 2.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.3 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 2.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 2.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 1.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.5 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 2.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 1.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.8 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:0071426 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0009219 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.1 | 0.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 3.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.1 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 1.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.2 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.1 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.1 | 1.7 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.4 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 3.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 3.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.5 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 2.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.5 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.3 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 1.0 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 2.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.1 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 2.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.7 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 1.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.5 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 1.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
0.1 | 0.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.1 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.6 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.5 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 1.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.1 | 0.7 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 2.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 4.3 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.7 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.1 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 2.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.4 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.2 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.0 | 0.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.0 | 1.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.0 | 0.2 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.0 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 1.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 1.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.0 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.0 | 0.1 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.2 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 1.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.4 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.6 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.3 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 2.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.2 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 1.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 1.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.0 | 0.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.4 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.2 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.0 | 0.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 1.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.5 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0033083 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.7 | 5.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 1.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 2.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 2.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 3.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 5.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 2.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 3.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 1.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 2.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 3.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 3.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 2.8 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 2.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.3 | GO:0036452 | ESCRT III complex(GO:0000815) ESCRT complex(GO:0036452) |
0.3 | 2.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.3 | 4.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 2.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 10.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 2.6 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.7 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 8.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 3.0 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 11.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.4 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 3.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 1.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.3 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.2 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 9.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 1.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 13.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 7.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 2.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 2.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 6.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 2.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0045180 | basal cortex(GO:0045180) cell cortex region(GO:0099738) |
0.1 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 2.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 2.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 2.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 25.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 7.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 9.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 3.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0000803 | sex chromosome(GO:0000803) XY body(GO:0001741) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 16.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 4.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.8 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 4.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 1.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 17.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.1 | GO:0030894 | replisome(GO:0030894) |
0.1 | 1.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 2.0 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.6 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 3.6 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.9 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 4.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 3.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 3.0 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.5 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.6 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 2.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 4.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 2.0 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 40.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.0 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 2.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 1.4 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 16.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 1.1 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 2.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 1.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 35.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 1.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.2 | 4.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 2.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 3.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.8 | 4.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 6.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 2.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 1.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 3.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 1.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 1.8 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.6 | 4.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.6 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 2.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 2.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 2.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 4.1 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 2.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 6.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 3.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 2.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 1.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 3.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 1.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 2.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 0.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 1.5 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 0.8 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.4 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 1.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 1.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 3.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 2.8 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 3.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 1.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 2.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 2.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 0.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 0.3 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 10.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 2.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 5.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 2.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 12.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.8 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 1.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 2.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 1.0 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 1.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.0 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 3.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 2.1 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 1.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 3.9 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 3.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 1.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 3.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 3.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 2.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 2.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 5.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 3.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.6 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 2.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 4.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 0.5 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.0 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 3.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 2.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 5.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 5.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 1.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 1.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 3.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 7.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 1.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 2.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 2.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 1.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 2.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 16.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.6 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 1.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 7.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 8.1 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 2.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 2.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 3.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.2 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 10.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 2.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.5 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 4.4 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 4.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 1.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 5.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 1.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 1.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 4.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 6.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.1 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 1.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 3.3 | GO:0070738 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.0 | 1.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 2.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 1.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 1.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 3.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 1.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 2.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 1.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 5.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 11.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 3.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.9 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 8.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 17.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 15.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 9.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 7.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 3.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 6.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 4.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 8.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 4.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 5.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 5.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 2.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 4.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 3.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 5.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 7.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 8.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 6.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 0.9 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.4 | 6.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 3.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 11.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 1.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 4.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 6.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 3.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 4.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 2.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 2.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 3.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 19.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 13.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 10.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 5.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 3.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.9 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 7.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 8.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 3.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 4.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 4.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 10.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 6.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 2.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.0 | 0.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 5.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 1.3 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 2.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |